| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
739,249
|
755,763
|
691,416
|
700,517
| | Cost of Revenue | 374,992 | 381,895 | 345,641 | 344,909 | | |
Gross Profit
|
364,257
|
373,868
|
345,775
|
355,608
| |
|
Operating Expenses |
|
Research Development | 41,454 | 62,992 | 40,562 | 40,447 |
|
Selling General and Administrative | 292,314 | 309,888 | 266,481 | 280,807 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
30,489
|
988
|
38,732
|
34,354
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (470) | (4,613) | (1,072) | 3,811 |
|
Earnings Before Interest And Taxes | 30,019 | (3,625) | 37,660 | 38,165 |
|
Interest Expense | 57,399 | 79,441 | 54,861 | 55,531 |
|
Income Before Tax | (27,380) | (83,066) | (17,201) | (17,366) |
|
Income Tax Expense | (36,871) | (17,698) | (10,677) | (489) |
|
Minority Interest | 25 | (138) | (286) | (36) |
|
|
|
Net Income From Continuing Ops | 12,450 | (62,403) | (3,803) | (12,915) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
12,450
|
(62,678)
|
(3,803)
|
(12,915)
| | Preferred Stock And Other Adjustments | (5,250) | (5,353) | (5,352) | (5,279) | | |
Net Income Applicable To Common Shares
|
7,200
|
(68,031)
|
(9,155)
|
(18,194)
|
|